Oxygen-Boosting injection may help rectal cancer patients avoid surgery
NCT ID NCT07622017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting a special solution (KRC-01) into rectal tumors before radiation can make the radiation work better. The solution increases oxygen inside the tumor, which helps radiation kill cancer cells. About 24 adults with advanced rectal cancer that hasn't spread will receive this treatment along with standard chemoradiotherapy. The goal is to see if more patients can achieve a complete response and possibly avoid surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gustave Roussy
Villejuif, Val de Marne, 94800, France
-
Institut Bergonié
Bordeaux, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Which rectal cancer surgery preserves quality of life better? a study investigates
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- Can AI learn to grade endoscopy quality from video?
- Could cutting one amino acid make rectal cancer treatment more effective?
- Can precision protons spare rectal cancer patients from harsh side effects?